Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 22, 2023BloodOpen Access

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJan P. NicolayGerman Cancer Research CenterSMSusanne MelchersGerman Cancer Research CenterJAJ. AlbrechtGerman Cancer Research Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nicolay et al. (2023) studied this question.

synapsesocial.com/papers/6a732fddcf0b0d0ea2c8f2edhttps://doi.org/10.1182/blood.2022018669
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HIV-1 Trans-Activator of Transcription Substitutes for Oxidative Signaling in Activation-Induced T Cell Death2005 · 108 citations
  2. 2Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients2020 · 85 citations
  3. 3Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas2020 · 19 citations
  4. 4Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study2019 · 238 citations
  5. 5Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma2020 · 49 citations